RINVOQ™ (Upadacitinib), approved for the Treatment of Psoriatic Arthritis and Ankylosing Spondylitis
The European Commission (EC) has approved RINVOQTM (upadacitinib, 15 mg), an…
XALKORI (CRIZOTINIB) approved for ALK-POSITIVE anaplastic large cell LYMPHOMA in children and young adults
The FDA has approved the supplemental New Drug Application (sNDA) for XALKORI®…
Enhertu (trastuzumab deruxtecan) first HER2-directed medicine approved in a decade for patients with HER2-positive metastatic gastric cancer
AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)’s Enhertu…
Xofluza® (baloxavir marboxil), a first-in-class, single-dose oral medicine, for the treatment of influenza,
The European Commission (EC) has approved Xofluza® (baloxavir marboxil) for the…
Glucagon for injection USP, First Generic of Drug Used to Treat Severe Hypoglycemia
The FDA has approved the first generic of glucagon for injection USP, 1 mg/vial…
Ibrance, Palbociclib, is the #1 prescribed, FDA-approved oral combination treatment for HR+, HER2- mBC.
IBRANCE® IS THE FIRST FDA-APPROVED MEDICATION in its class. IBRANCE is a…
Libmeldy, world’s first lentiviral vector-based gene therapy for the treatment of metachromatic leukodystrophy (MLD)
The European Commission officially announced full approval for the world’s…
PALFORZIA® [defatted powder of Arachis hypogaea L., semen (peanuts)]approved in the EU for the treatment of peanut allergy
PALFORZIA is an oral immunotherapy indicated in patients aged 4 to 17 years,…
Tagrisso (osimertinib) , First Adjuvant Therapy for Most Common Type of Lung Cancer
The U.S. Food and Drug Administration has approved Tagrisso (osimertinib) as…
Gallium 68 PSMA-11 (Ga 68 PSMA-11)is the First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer
U.S. Food and Drug Administration has approved Gallium 68 PSMA-11 (Ga 68…